Rigel Pharmaceuticals (RIGL) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -46.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.62% |
| Dec 31, 2025 | -28.49% |
| Sep 30, 2025 | -6.11% |
| Jun 30, 2025 | 48.13% |
| Mar 31, 2025 | 78.81% |
| Dec 31, 2024 | 73.08% |
| Sep 30, 2024 | 13.82% |
| Jun 30, 2024 | -26.14% |
| Mar 31, 2024 | -36.52% |
| Dec 31, 2023 | 34.04% |
| Sep 30, 2023 | 52.06% |
| Jun 30, 2023 | 79.45% |
| Mar 31, 2023 | 63.24% |
| Dec 31, 2022 | 29.48% |
| Sep 30, 2022 | -1.77% |
| Jun 30, 2022 | -67.93% |
| Mar 31, 2022 | 23.11% |
| Dec 31, 2021 | -37.81% |
| Sep 30, 2021 | -16.86% |
| Jun 30, 2021 | 132.59% |
| Mar 31, 2021 | -55.67% |
| Dec 31, 2020 | 34.87% |
| Sep 30, 2020 | -6.46% |
| Jun 30, 2020 | -17.55% |
| Mar 31, 2020 | -39.45% |
| Dec 31, 2019 | -70.49% |
| Sep 30, 2019 | -36.42% |
| Jun 30, 2019 | -32.04% |
| Mar 31, 2019 | 86.16% |
| Dec 31, 2018 | 99.33% |
| Sep 30, 2018 | 137.59% |
| Jun 30, 2018 | 99.68% |
| Mar 31, 2018 | -0.05% |
| Dec 31, 2017 | 117.16% |
| Sep 30, 2017 | -0.27% |
| Jun 30, 2017 | 30.65% |
| Mar 31, 2017 | 181.34% |
| Dec 31, 2016 | -59.43% |
| Sep 30, 2016 | -32.73% |
| Jun 30, 2016 | 44.28% |
| Mar 31, 2016 | -66.60% |
| Dec 31, 2015 | 185.84% |
| Sep 30, 2015 | 201.05% |
| Jun 30, 2015 | -27.60% |
| Mar 31, 2015 | 186.51% |
| Dec 31, 2014 | -27.10% |
| Sep 30, 2014 | -20.07% |
| Jun 30, 2014 | 9.21% |
| Mar 31, 2014 | -56.35% |
| Dec 31, 2013 | -37.72% |
| Sep 30, 2013 | -40.19% |
| Jun 30, 2013 | -16.38% |
| Mar 31, 2013 | 55.04% |
| Dec 31, 2012 | 79.70% |
| Sep 30, 2012 | 43.46% |
| Jun 30, 2012 | -39.12% |
| Mar 31, 2012 | -14.29% |
| Dec 31, 2011 | 109.90% |
| Sep 30, 2011 | -15.31% |
| Jun 30, 2011 | 33.27% |